Citation Impact
Citing Papers
Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors
2005
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment
2001
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor
2001
Hallmarks of Cancer: The Next Generation
2011 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Functional Gastroduodenal Disorders
2006 Standout
Sjögren's syndrome
2005 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type
1999
Lymphoid Malignancies: the dark side of B-cell differentiation
2002
Primary gastric B-Cell lymphoma: Results of a prospective multicenter study
2000
Lung Cancer
2008 Standout
Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5
2003
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Helicobacter heilmannii–associated primary gastric low-grade MALT lymphoma: Complete remission after curing the infection
2000
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
2004 Standout
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
2009 StandoutNobel
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Helicobacter pylori-associated diseases
2002
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
Treatment of Acute Lymphoblastic Leukemia
2006
Targeting the Met signaling pathway in renal cancer
2009
The primary transcriptome of the major human pathogen Helicobacter pylori
2010 StandoutNature
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial
2002
Met, metastasis, motility and more
2003 Standout
Helicobacter pyloriInfection
2002 Standout
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
2002
Regulatory T cells in tumor immunity
2010 StandoutNobel
Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells
2013
Guidelines for the management of Helicobacter pylori infection
1998
Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study
2003
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series
2003
Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease
2001
Microbiome and Malignancy
2011
Lyme borreliosis
2011 Standout
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Effect of Helicobacter Pylori Eradication on Subsequent Development of Cancer after Endoscopic Resection of Early Gastric Cancer in Japan
2000
Non–Gastrointestinal Tract Associations of Helicobacter pylori Infection
1999
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
K252a inhibits the oncogenic properties of Met, the HGF receptor
2002
The human microbiome: at the interface of health and disease
2012 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Epidemiology of lymphomas
2000
Comparison of Cytogenetic and Molecular Genetic Detection of t(8;21) and inv(16) in a Prospective Series of Adults With De Novo Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
2001
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
2006
The gastric marginal zone B-cell lymphoma of MALT type
2000
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Primary Human Lymphocytes Transduced with NY-ESO-1 Antigen-Specific TCR Genes Recognize and Kill Diverse Human Tumor Cell Lines
2005
Identification of the Genes for Kidney Cancer: Opportunity for Disease-Specific Targeted Therapeutics
2007
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
2003
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
2002
Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group
2003
Clinical Manifestations and Diagnosis of Lyme Borreliosis
2009
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
The gastric marginal zone B-cell lymphoma of MALT type
2000
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin
2005
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup
2004
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Birgit Alpen being referenced
Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
1997
Helicobacter and gastric MALT lymphoma
2002
Clonal relationship in multifocal non-Hodgkin?s lymphoma of mucosa-associated lymphoid tissue (MALT)
2004
What Role Does Helicobacter pylori Eradication Play in Gastric MALT and Gastric MALT Lymphoma?
1997
Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma.
1998
Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation
1997
Long-term follow-up of gastric malt lymphoma after H. pylori eradication
2001
A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved
2002
Eradication of Helicobacter pylori and Stability of Remissions in Low-Grade Gastric B-Cell Lymphomas of the Mucosa-Associated Lymphoid Tissue: Results of an Ongoing Multicenter Trial
2000
Long-Term Persistence of Monoclonal B Cells After Cure of Helicobacter pylori Infection and Complete Histologic Remission in Gastric Mucosa–Associated Lymphoid Tissue B-Cell Lymphoma
2001
Frequency ofTPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives
2000
Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication ofHelicobacter pylori infection
2000